What's in Invivyd, Inc.'s pipeline?

Invivyd, Inc. has 5 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 1 in Phase 2, 1 in Phase 1.

Which companies overlap with Invivyd, Inc.'s portfolio?

Top competitors by shared drug class: Pfizer, Aeras, Alba Maria Ropero, Agomab Spain S.L., Aimei Vacin BioPharm (Zhejiang) Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/invivyd-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Invivyd, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Invivyd, Inc. pipeline: 0 marketed, 0 filed, 3 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 1 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
VYD2311-MD	VYD2311-MD	phase 3	monoclonal antibody	SARS-CoV-2 spike protein	Infectious Disease
VYD2311-SD	VYD2311-SD	phase 3	vaccine		Infectious Disease
VYD222 (pemivibart)	VYD222 (pemivibart)	phase 3	Antiviral	SARS-CoV-2 RNA-dependent RNA polymerase (RdRp)	Infectious Disease

Therapeutic area mix

Infectious Disease · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Pfizer · 3 shared drug classes
Aeras · 1 shared drug class
Alba Maria Ropero · 1 shared drug class
Agomab Spain S.L. · 1 shared drug class
Aimei Vacin BioPharm (Zhejiang) Co., Ltd. · 1 shared drug class
Ain Shams University · 1 shared drug class
Aga Khan University · 1 shared drug class
Aduro Biotech, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Invivyd, Inc.:

Cite this brief

Drug Landscape (2026). Invivyd, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/invivyd-inc. Accessed 2026-06-10.